Amy W. Schulman
CIK: 0001438226
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 20, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
Award(A)Direct838 shares- - May 13, 2026ELV
Elevance Health, Inc.
Award(A)Direct563 shares- - May 13, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
Exercise(M)Direct11.3K shares at avg. $70.20$790K - Mar 12, 2026ELV
Elevance Health, Inc.
Sale(S)Direct26 shares at avg. $287.50$7K - Feb 2, 2026ELV
Elevance Health, Inc.
Award(A)Direct218 shares- - Jun 11, 2025GUTS
FRACTYL HEALTH, INC.
Award(A)DirectStock Option
22.5K shares- - May 8, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
Award(A)Direct775 shares- - Mar 13, 2025GUTS
FRACTYL HEALTH, INC.
Purchase(P)Direct8.6K shares at avg. $1.17$10K - Mar 13, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
Exercise(M)Direct2.8K shares at avg. $131.21$361K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Award(A) | 838 | - | $0 | Direct |
| May 13, 2026 |  ELV Elevance Health, Inc. | Award(A) | 563 | - | $0 | Direct |
| May 13, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Exercise(M) | 11,250 | $70.20 | $789,750 | Direct |
| Mar 12, 2026 | ELV Elevance Health, Inc. | Sale(S) | 26 | $287.50 | $7,475 | Direct |
| Feb 2, 2026 | ELV Elevance Health, Inc. | Award(A) | 218 | - | $0 | Direct |
| Jun 11, 2025 |  GUTS FRACTYL HEALTH, INC. | Award(A) Stock Option | 22,500 | - | - | Direct |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Award(A) | 775 | - | - | Direct |
| Mar 13, 2025 | GUTS FRACTYL HEALTH, INC. | Purchase(P) | 8,550 | $1.17 | $9,964 | Direct |
| Mar 13, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Exercise(M) | 2,750 | $131.21 | $360,828 | Direct |
1-9 of 9 transactions
About SCHULMAN AMY W
SCHULMAN AMY W (SEC CIK 0001438226) files insider reports with the SEC as Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY), Director of Elevance Health, Inc. (ELV) and Director of FRACTYL HEALTH, INC. (GUTS).
Signal8 holds 10 ownership filings by SCHULMAN AMY W (1 Form 3, 9 Form 4), filed between Mar 14, 2025 and May 22, 2026. Those filings report 9 transactions, from Mar 13, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SCHULMAN AMY W's filings is in INDIANAPOLIS, IN.
Recent filings by SCHULMAN AMY W
- May 20, 2026: Grant or award of ALNY shares (Form 4, code A).
- May 13, 2026: Grant or award of ELV shares (Form 4, code A).
- May 13, 2026: Option exercise of ALNY shares (Form 4, code M).
- Mar 12, 2026: Open-market sale of ELV shares (Form 4, code S).
- Feb 2, 2026: Grant or award of ELV shares (Form 4, code A).
Other insiders filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- SUPRAN BRYAN, EVP, CLO and Secretary
- Greenstreet Yvonne, Chief Executive Officer
- PYOTT DAVID E I, Director
- Cravatt Benjamin, Director
- Sigal Charles Elliott, Director
- Reitan Colleen F, Director